Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cryosurgery | 9 | 2024 | 475 | 2.310 |
Why?
|
Radiology, Interventional | 5 | 2021 | 475 | 2.250 |
Why?
|
Ablation Techniques | 10 | 2023 | 248 | 2.220 |
Why?
|
Radiography, Interventional | 15 | 2018 | 1114 | 1.930 |
Why?
|
Adrenal Gland Neoplasms | 4 | 2019 | 733 | 1.500 |
Why?
|
Radiology | 6 | 2024 | 2102 | 1.480 |
Why?
|
Catheter Ablation | 12 | 2023 | 2758 | 1.280 |
Why?
|
Surgery, Computer-Assisted | 9 | 2023 | 1008 | 1.210 |
Why?
|
Tomography, X-Ray Computed | 45 | 2019 | 20509 | 1.180 |
Why?
|
Microwaves | 7 | 2021 | 185 | 0.920 |
Why?
|
Kidney Neoplasms | 12 | 2023 | 4312 | 0.880 |
Why?
|
Carcinoma, Renal Cell | 10 | 2023 | 3218 | 0.830 |
Why?
|
Checklist | 2 | 2022 | 827 | 0.820 |
Why?
|
Ultrasonography, Interventional | 4 | 2013 | 1502 | 0.790 |
Why?
|
Radiography | 7 | 2023 | 6965 | 0.650 |
Why?
|
Thoracic Wall | 1 | 2019 | 199 | 0.600 |
Why?
|
Speech Recognition Software | 1 | 2017 | 74 | 0.570 |
Why?
|
Radiology Department, Hospital | 1 | 2021 | 405 | 0.560 |
Why?
|
Urolithiasis | 4 | 2019 | 132 | 0.530 |
Why?
|
Liver Neoplasms | 7 | 2021 | 4319 | 0.500 |
Why?
|
Catecholamines | 1 | 2015 | 385 | 0.480 |
Why?
|
Pleural Neoplasms | 1 | 2019 | 609 | 0.480 |
Why?
|
Diagnostic Imaging | 4 | 2018 | 3527 | 0.470 |
Why?
|
Adrenalectomy | 1 | 2015 | 348 | 0.450 |
Why?
|
Magnetic Resonance Imaging, Interventional | 2 | 2013 | 187 | 0.440 |
Why?
|
Infection Control | 1 | 2021 | 983 | 0.440 |
Why?
|
Radiation Protection | 4 | 2015 | 425 | 0.430 |
Why?
|
Obesity | 8 | 2021 | 12922 | 0.420 |
Why?
|
Electronic Health Records | 2 | 2022 | 4775 | 0.400 |
Why?
|
Radiation Dosage | 5 | 2018 | 1958 | 0.390 |
Why?
|
Neurilemmoma | 1 | 2017 | 523 | 0.390 |
Why?
|
Embolization, Therapeutic | 4 | 2021 | 1413 | 0.380 |
Why?
|
Patient Care Planning | 1 | 2016 | 908 | 0.370 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 716 | 0.360 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2019 | 1215 | 0.350 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2018 | 951 | 0.350 |
Why?
|
Medical Oncology | 1 | 2021 | 2313 | 0.330 |
Why?
|
Transportation of Patients | 2 | 2007 | 176 | 0.320 |
Why?
|
Vena Cava Filters | 2 | 2024 | 261 | 0.320 |
Why?
|
Nephrectomy | 2 | 2018 | 1016 | 0.320 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2009 | 82 | 0.310 |
Why?
|
Injections, Intra-Articular | 1 | 2009 | 279 | 0.310 |
Why?
|
Bone Neoplasms | 2 | 2019 | 2532 | 0.310 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2512 | 0.310 |
Why?
|
Humans | 97 | 2024 | 760621 | 0.300 |
Why?
|
Nephrolithiasis | 1 | 2009 | 114 | 0.300 |
Why?
|
Hepatectomy | 3 | 2021 | 559 | 0.290 |
Why?
|
Ureteral Obstruction | 1 | 2009 | 292 | 0.290 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2557 | 0.270 |
Why?
|
Internship and Residency | 3 | 2024 | 5870 | 0.260 |
Why?
|
Radiographic Image Enhancement | 2 | 2009 | 875 | 0.250 |
Why?
|
Pain | 2 | 2019 | 5066 | 0.250 |
Why?
|
Arthralgia | 1 | 2009 | 461 | 0.250 |
Why?
|
Palliative Care | 2 | 2021 | 3607 | 0.250 |
Why?
|
Urologic Diseases | 1 | 2008 | 248 | 0.250 |
Why?
|
Lymphatic Metastasis | 6 | 2018 | 2943 | 0.250 |
Why?
|
Curriculum | 4 | 2024 | 3718 | 0.240 |
Why?
|
Coronary Angiography | 2 | 2009 | 4563 | 0.240 |
Why?
|
Steroids | 1 | 2009 | 928 | 0.240 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2021 | 2299 | 0.230 |
Why?
|
Wounds, Nonpenetrating | 2 | 2001 | 793 | 0.230 |
Why?
|
Biopsy | 3 | 2013 | 6771 | 0.230 |
Why?
|
Cerebral Angiography | 1 | 2010 | 1274 | 0.230 |
Why?
|
Decision Making | 1 | 2018 | 3925 | 0.230 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9276 | 0.220 |
Why?
|
Absorptiometry, Photon | 1 | 2009 | 1736 | 0.220 |
Why?
|
Fournier Gangrene | 1 | 2003 | 22 | 0.210 |
Why?
|
Neoplasms | 4 | 2023 | 22072 | 0.210 |
Why?
|
Anesthetics, Local | 1 | 2009 | 1001 | 0.210 |
Why?
|
Kidney Diseases | 2 | 2010 | 2093 | 0.210 |
Why?
|
Middle Aged | 49 | 2024 | 220352 | 0.200 |
Why?
|
Treatment Outcome | 18 | 2024 | 65017 | 0.200 |
Why?
|
Retrospective Studies | 29 | 2021 | 80372 | 0.190 |
Why?
|
Iliac Vein | 1 | 2001 | 70 | 0.190 |
Why?
|
Preoperative Care | 2 | 2008 | 2256 | 0.190 |
Why?
|
Alloys | 1 | 2001 | 113 | 0.190 |
Why?
|
Aged, 80 and over | 22 | 2024 | 58995 | 0.190 |
Why?
|
Male | 55 | 2024 | 359744 | 0.180 |
Why?
|
User-Computer Interface | 2 | 2017 | 1403 | 0.180 |
Why?
|
Coronary Vessel Anomalies | 1 | 2004 | 317 | 0.180 |
Why?
|
Brown-Sequard Syndrome | 1 | 1999 | 3 | 0.180 |
Why?
|
Aged | 37 | 2024 | 169152 | 0.170 |
Why?
|
Intracranial Aneurysm | 1 | 2010 | 1276 | 0.170 |
Why?
|
Wounds, Stab | 1 | 1999 | 72 | 0.170 |
Why?
|
Cholecystectomy | 1 | 2021 | 406 | 0.170 |
Why?
|
Pneumocephalus | 1 | 1999 | 47 | 0.170 |
Why?
|
Radio Waves | 2 | 2017 | 250 | 0.160 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 2363 | 0.160 |
Why?
|
Ribs | 1 | 2000 | 252 | 0.160 |
Why?
|
Liver Diseases | 4 | 2014 | 1302 | 0.160 |
Why?
|
Device Removal | 1 | 2024 | 636 | 0.160 |
Why?
|
Vascular Diseases | 3 | 2010 | 1182 | 0.160 |
Why?
|
Tomography, Emission-Computed | 1 | 2001 | 1121 | 0.160 |
Why?
|
Models, Statistical | 3 | 2013 | 5075 | 0.160 |
Why?
|
Intestinal Perforation | 1 | 2000 | 250 | 0.150 |
Why?
|
Ureteral Diseases | 2 | 2008 | 65 | 0.150 |
Why?
|
Work Simplification | 1 | 2017 | 8 | 0.150 |
Why?
|
Neck Injuries | 1 | 1999 | 160 | 0.150 |
Why?
|
Drainage | 3 | 2015 | 1161 | 0.150 |
Why?
|
Female | 50 | 2024 | 391270 | 0.150 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2001 | 270 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 211 | 0.150 |
Why?
|
Positron-Emission Tomography | 2 | 2013 | 6465 | 0.150 |
Why?
|
Diagnosis, Differential | 11 | 2013 | 12965 | 0.140 |
Why?
|
Hernia, Inguinal | 1 | 2000 | 220 | 0.140 |
Why?
|
Abdominal Injuries | 1 | 2000 | 359 | 0.140 |
Why?
|
Liver Transplantation | 3 | 2021 | 2325 | 0.140 |
Why?
|
Workflow | 1 | 2022 | 852 | 0.140 |
Why?
|
Prosthesis Design | 1 | 2024 | 2135 | 0.140 |
Why?
|
Osteomalacia | 1 | 2016 | 56 | 0.140 |
Why?
|
Mesenchymoma | 1 | 2016 | 49 | 0.140 |
Why?
|
Electromagnetic Phenomena | 1 | 2017 | 161 | 0.130 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2019 | 200 | 0.130 |
Why?
|
Disease Progression | 4 | 2024 | 13502 | 0.130 |
Why?
|
Catheterization, Central Venous | 1 | 2000 | 526 | 0.120 |
Why?
|
Conscious Sedation | 2 | 2010 | 529 | 0.120 |
Why?
|
Task Performance and Analysis | 1 | 2018 | 759 | 0.110 |
Why?
|
Adult | 31 | 2024 | 219994 | 0.110 |
Why?
|
Predictive Value of Tests | 6 | 2018 | 15289 | 0.110 |
Why?
|
Tumor Burden | 2 | 2019 | 1895 | 0.110 |
Why?
|
Cholangiocarcinoma | 1 | 2019 | 550 | 0.110 |
Why?
|
Hydronephrosis | 3 | 2010 | 271 | 0.110 |
Why?
|
Glomerular Filtration Rate | 2 | 2019 | 2180 | 0.110 |
Why?
|
Urinary Calculi | 2 | 2019 | 91 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1238 | 0.110 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 730 | 0.110 |
Why?
|
Neoplasm Metastasis | 3 | 2024 | 4902 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 9 | 2017 | 36290 | 0.110 |
Why?
|
Contrast Media | 7 | 2012 | 5305 | 0.110 |
Why?
|
Pain Measurement | 2 | 2019 | 3528 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1993 | 0.100 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 597 | 0.100 |
Why?
|
Education, Medical, Continuing | 1 | 2018 | 830 | 0.100 |
Why?
|
Time Factors | 8 | 2024 | 40165 | 0.100 |
Why?
|
Neoplasm Staging | 6 | 2019 | 11152 | 0.100 |
Why?
|
Pelvic Neoplasms | 1 | 2014 | 248 | 0.100 |
Why?
|
Acidosis, Lactic | 1 | 2013 | 145 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2011 | 64 | 0.100 |
Why?
|
ROC Curve | 1 | 2019 | 3568 | 0.100 |
Why?
|
Phlebography | 2 | 2024 | 325 | 0.100 |
Why?
|
Neoplasm Invasiveness | 2 | 2018 | 3618 | 0.100 |
Why?
|
Program Development | 1 | 2017 | 1297 | 0.090 |
Why?
|
Uterine Artery | 1 | 2010 | 30 | 0.090 |
Why?
|
Barium Sulfate | 2 | 2008 | 180 | 0.090 |
Why?
|
Lymphangioma, Cystic | 1 | 2010 | 34 | 0.090 |
Why?
|
Lymphangiectasis | 1 | 2010 | 20 | 0.090 |
Why?
|
Information Dissemination | 1 | 2019 | 1131 | 0.090 |
Why?
|
Pulmonary Embolism | 1 | 2024 | 2543 | 0.090 |
Why?
|
Fluoroscopy | 2 | 2008 | 948 | 0.090 |
Why?
|
Angiomyolipoma | 1 | 2011 | 184 | 0.090 |
Why?
|
Catheterization | 1 | 2015 | 1432 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1287 | 0.090 |
Why?
|
Equipment Design | 1 | 2018 | 3520 | 0.090 |
Why?
|
Angiography | 4 | 2008 | 1605 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10182 | 0.080 |
Why?
|
Polycythemia | 1 | 2010 | 125 | 0.080 |
Why?
|
Stents | 1 | 2001 | 3314 | 0.080 |
Why?
|
Biliary Tract Diseases | 1 | 2010 | 157 | 0.080 |
Why?
|
Lymphoma | 1 | 2018 | 1898 | 0.080 |
Why?
|
Liver Abscess | 1 | 2009 | 81 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3736 | 0.080 |
Why?
|
Ferrosoferric Oxide | 1 | 2009 | 348 | 0.080 |
Why?
|
Radiography, Abdominal | 2 | 2009 | 532 | 0.080 |
Why?
|
Lactic Acid | 1 | 2013 | 1134 | 0.080 |
Why?
|
Glomerulonephritis | 1 | 2010 | 337 | 0.070 |
Why?
|
Iopamidol | 1 | 2008 | 186 | 0.070 |
Why?
|
Anesthesia, Local | 1 | 2010 | 276 | 0.070 |
Why?
|
Prognosis | 2 | 2019 | 29658 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 2016 | 1152 | 0.070 |
Why?
|
Paraproteinemias | 1 | 2010 | 246 | 0.070 |
Why?
|
Carcinoma, Small Cell | 1 | 2010 | 416 | 0.070 |
Why?
|
Body Mass Index | 3 | 2021 | 12914 | 0.070 |
Why?
|
Pilot Projects | 2 | 2019 | 8555 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2014 | 818 | 0.070 |
Why?
|
Kidney Glomerulus | 1 | 2010 | 568 | 0.070 |
Why?
|
Patient Positioning | 1 | 2010 | 327 | 0.070 |
Why?
|
Dextrans | 1 | 2009 | 574 | 0.070 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2009 | 265 | 0.070 |
Why?
|
Urinary Catheterization | 1 | 2008 | 198 | 0.070 |
Why?
|
Biliary Tract | 1 | 2008 | 135 | 0.070 |
Why?
|
Hypercalcemia | 1 | 2010 | 421 | 0.070 |
Why?
|
Esophagogastric Junction | 1 | 2009 | 341 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3465 | 0.070 |
Why?
|
Postpartum Hemorrhage | 1 | 2010 | 265 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3486 | 0.070 |
Why?
|
Clinical Competence | 2 | 2024 | 4783 | 0.070 |
Why?
|
Survival Rate | 2 | 2019 | 12808 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4122 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2018 | 2290 | 0.070 |
Why?
|
Technology Assessment, Biomedical | 1 | 2009 | 306 | 0.070 |
Why?
|
Risk Assessment | 5 | 2021 | 24123 | 0.070 |
Why?
|
Melanoma | 1 | 2024 | 5697 | 0.060 |
Why?
|
Combined Modality Therapy | 4 | 2024 | 8552 | 0.060 |
Why?
|
Metformin | 1 | 2013 | 912 | 0.060 |
Why?
|
Emergency Treatment | 1 | 2009 | 498 | 0.060 |
Why?
|
Ureter | 1 | 2008 | 375 | 0.060 |
Why?
|
Posture | 1 | 2009 | 953 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3849 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12531 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2007 | 0.060 |
Why?
|
Cold Temperature | 1 | 2008 | 780 | 0.060 |
Why?
|
Abdominal Pain | 4 | 2013 | 1063 | 0.060 |
Why?
|
Equipment and Supplies | 1 | 2007 | 275 | 0.060 |
Why?
|
Sirolimus | 1 | 2011 | 1547 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5253 | 0.060 |
Why?
|
Decompression, Surgical | 1 | 2009 | 604 | 0.060 |
Why?
|
Intestinal Obstruction | 1 | 2008 | 434 | 0.060 |
Why?
|
Adolescent | 10 | 2018 | 87810 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5325 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2013 | 2634 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3763 | 0.060 |
Why?
|
Tuberous Sclerosis | 1 | 2011 | 1030 | 0.050 |
Why?
|
Odds Ratio | 1 | 2015 | 9716 | 0.050 |
Why?
|
Logistic Models | 2 | 2015 | 13314 | 0.050 |
Why?
|
Risk Factors | 7 | 2021 | 74359 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15757 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5643 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2008 | 8950 | 0.050 |
Why?
|
Scrotum | 1 | 2003 | 116 | 0.050 |
Why?
|
Electroporation | 1 | 2023 | 255 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12159 | 0.050 |
Why?
|
Delaware | 1 | 2001 | 12 | 0.050 |
Why?
|
Tissue Plasminogen Activator | 1 | 2008 | 1190 | 0.050 |
Why?
|
Radiology Information Systems | 1 | 2006 | 528 | 0.050 |
Why?
|
Child, Preschool | 4 | 2017 | 42063 | 0.050 |
Why?
|
Intestine, Small | 1 | 2008 | 1207 | 0.050 |
Why?
|
Placenta | 1 | 2010 | 1702 | 0.050 |
Why?
|
Colon | 1 | 2009 | 1788 | 0.050 |
Why?
|
Kidney | 3 | 2013 | 7064 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1431 | 0.050 |
Why?
|
Maxillary Artery | 1 | 2000 | 18 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8624 | 0.050 |
Why?
|
Vena Cava, Inferior | 1 | 2024 | 458 | 0.050 |
Why?
|
Ultrasonography, Doppler | 1 | 2003 | 465 | 0.040 |
Why?
|
Sensitivity and Specificity | 5 | 2015 | 14660 | 0.040 |
Why?
|
Pelvis | 2 | 2018 | 743 | 0.040 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2852 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1274 | 0.040 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2007 | 800 | 0.040 |
Why?
|
Endoscopy | 1 | 2010 | 1838 | 0.040 |
Why?
|
Epistaxis | 1 | 2000 | 111 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2000 | 124 | 0.040 |
Why?
|
Synovial Cyst | 1 | 1999 | 35 | 0.040 |
Why?
|
Carotid Artery, Common | 1 | 2000 | 177 | 0.040 |
Why?
|
Hepatitis C | 1 | 2010 | 1579 | 0.040 |
Why?
|
Rupture, Spontaneous | 2 | 2010 | 356 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2000 | 516 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6828 | 0.040 |
Why?
|
Young Adult | 7 | 2019 | 58741 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2024 | 594 | 0.040 |
Why?
|
Creatinine | 2 | 2018 | 1903 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2009 | 1648 | 0.040 |
Why?
|
Paraganglioma | 1 | 2000 | 142 | 0.040 |
Why?
|
Vascular Neoplasms | 1 | 2000 | 167 | 0.040 |
Why?
|
Image Enhancement | 1 | 2009 | 2881 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 2167 | 0.040 |
Why?
|
Retroperitoneal Space | 1 | 2018 | 173 | 0.040 |
Why?
|
Nanoparticles | 1 | 2009 | 1943 | 0.040 |
Why?
|
Equipment Failure | 1 | 2000 | 577 | 0.040 |
Why?
|
Arteriovenous Malformations | 1 | 2000 | 397 | 0.040 |
Why?
|
United States | 2 | 2021 | 72461 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2001 | 13262 | 0.040 |
Why?
|
Health Facilities | 1 | 2021 | 578 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2942 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2000 | 1975 | 0.030 |
Why?
|
Glucose | 1 | 2008 | 4351 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39261 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5877 | 0.030 |
Why?
|
Edema | 2 | 2010 | 769 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 529 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2018 | 681 | 0.030 |
Why?
|
Hemorrhage | 1 | 2008 | 3600 | 0.030 |
Why?
|
Thigh | 1 | 2016 | 240 | 0.030 |
Why?
|
Leiomyoma | 1 | 2000 | 654 | 0.030 |
Why?
|
Pancreas | 2 | 2013 | 1677 | 0.030 |
Why?
|
Spinal Diseases | 1 | 1999 | 559 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2024 | 1299 | 0.030 |
Why?
|
Inguinal Canal | 1 | 2014 | 71 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2007 | 2276 | 0.030 |
Why?
|
Reoperation | 2 | 2018 | 4291 | 0.030 |
Why?
|
Ultrasonography | 3 | 2013 | 5961 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3084 | 0.030 |
Why?
|
Cervical Vertebrae | 1 | 1999 | 978 | 0.030 |
Why?
|
Mesentery | 1 | 2014 | 202 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5201 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2010 | 4878 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7408 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2014 | 236 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2018 | 1440 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2012 | 110 | 0.030 |
Why?
|
Liver | 1 | 2008 | 7509 | 0.030 |
Why?
|
Coloring Agents | 1 | 2014 | 562 | 0.020 |
Why?
|
Spinal Cord Injuries | 1 | 1999 | 924 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6315 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2018 | 1268 | 0.020 |
Why?
|
Spinal Cord | 1 | 1999 | 1817 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 2000 | 1439 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3844 | 0.020 |
Why?
|
Observer Variation | 2 | 2008 | 2601 | 0.020 |
Why?
|
Vulvar Neoplasms | 1 | 2014 | 263 | 0.020 |
Why?
|
Confusion | 1 | 2013 | 279 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1596 | 0.020 |
Why?
|
Suicide, Attempted | 1 | 1999 | 1378 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 869 | 0.020 |
Why?
|
Lung | 1 | 2009 | 9994 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5351 | 0.020 |
Why?
|
Ascitic Fluid | 1 | 2010 | 189 | 0.020 |
Why?
|
Hospitals | 1 | 2024 | 3928 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6544 | 0.020 |
Why?
|
Child | 5 | 2018 | 79806 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 1999 | 1868 | 0.020 |
Why?
|
Vomiting | 1 | 2013 | 650 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2006 | 14495 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2009 | 6853 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7475 | 0.020 |
Why?
|
Infant | 3 | 2008 | 36060 | 0.020 |
Why?
|
Boston | 2 | 2015 | 9280 | 0.020 |
Why?
|
Body Size | 1 | 2012 | 462 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2013 | 2502 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2015 | 20080 | 0.020 |
Why?
|
Mesenteric Artery, Superior | 1 | 2008 | 95 | 0.020 |
Why?
|
Bronchiectasis | 1 | 2009 | 139 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3310 | 0.020 |
Why?
|
Hematocrit | 1 | 2009 | 629 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 221 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2009 | 316 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 2014 | 1303 | 0.020 |
Why?
|
Infusion Pumps, Implantable | 1 | 2008 | 157 | 0.020 |
Why?
|
Chest Tubes | 1 | 2008 | 152 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 2234 | 0.020 |
Why?
|
Hepatic Artery | 1 | 2008 | 230 | 0.020 |
Why?
|
Proteinuria | 1 | 2010 | 594 | 0.020 |
Why?
|
Iohexol | 1 | 2008 | 204 | 0.020 |
Why?
|
England | 1 | 2008 | 526 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3016 | 0.020 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2010 | 325 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2009 | 351 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2010 | 2558 | 0.020 |
Why?
|
Aortography | 1 | 2008 | 420 | 0.020 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 329 | 0.020 |
Why?
|
Pancreatitis | 1 | 2013 | 1100 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1191 | 0.020 |
Why?
|
Portal Vein | 1 | 2008 | 429 | 0.020 |
Why?
|
Esophagectomy | 1 | 2009 | 466 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5799 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2009 | 1832 | 0.010 |
Why?
|
Endometrial Neoplasms | 1 | 2014 | 1357 | 0.010 |
Why?
|
Gastrectomy | 1 | 2009 | 679 | 0.010 |
Why?
|
Administration, Oral | 1 | 2012 | 4035 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1791 | 0.010 |
Why?
|
Bone Density | 1 | 2016 | 3534 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1376 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2008 | 1007 | 0.010 |
Why?
|
Prospective Studies | 3 | 2014 | 54303 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16939 | 0.010 |
Why?
|
Cost Savings | 1 | 2008 | 920 | 0.010 |
Why?
|
Gastroesophageal Reflux | 1 | 2009 | 816 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 2003 | 0.010 |
Why?
|
Water | 1 | 2008 | 1407 | 0.010 |
Why?
|
Body Weight | 1 | 2012 | 4611 | 0.010 |
Why?
|
Myelography | 1 | 1999 | 72 | 0.010 |
Why?
|
Louisiana | 1 | 1999 | 104 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1999 | 374 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2009 | 1931 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41335 | 0.010 |
Why?
|
Premature Birth | 1 | 2010 | 1771 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4024 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 1941 | 0.010 |
Why?
|
Postoperative Complications | 2 | 2016 | 15697 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3340 | 0.010 |
Why?
|
Uterus | 1 | 2000 | 651 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2008 | 10827 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23376 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4048 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29932 | 0.010 |
Why?
|
Anticoagulants | 1 | 2008 | 4897 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12293 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 29749 | 0.000 |
Why?
|
Graft Survival | 1 | 1999 | 3794 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13630 | 0.000 |
Why?
|
HIV Infections | 1 | 2010 | 17165 | 0.000 |
Why?
|